Delivery Order SPE2DX22D0049-SPE2D826FA6HS
Award Date 4/6/26
Potential Completion Date 4/7/26
Potential Value $43K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain issued a $4,955.04 delivery order to AmerisourceBergen Drug Corp on April 6, 2026, under its parent Indefinite Delivery Contract with the DLA Troop Support Medical for pharmaceutical products and medical supplies. The parent IDC, valued at $999,999,999.00 and running through December 2026, supports military healthcare programs globally with a comprehensive range of pharmaceutical products, brand-name and generic drugs, vaccines, syringes,...
- The Defense Logistics Agency Medical Supply Chain issued a $121,860.06 delivery order to AmerisourceBergen Drug Corp on April 2, 2026, for pharmaceutical products under its parent Indefinite Delivery Contract with the DLA Troop Support Medical. The parent IDC, valued at up to $999,999,999.00 and extending through December 2026, supports global pharmaceutical and medical supply delivery to military healthcare programs. Place of performance is Conshohocken, PA. The order carries a firm fixed price...
- The Defense Logistics Agency Medical Supply Chain issued a $32,134.20 delivery order to AmerisourceBergen Drug Corp on April 6, 2026, for pharmaceutical products under its parent Indefinite Delivery Contract with the DLA Troop Support Medical. The parent IDC, valued at $999,999,999.00 and running through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military...
- The Defense Logistics Agency Medical Supply Chain issued a $636,808.50 delivery order to AmerisourceBergen Drug Corp on April 6, 2026, for pharmaceutical products under its parent Indefinite Delivery Contract with the DLA Troop Support Medical. The parent IDC, valued at up to $999,999,999.00 and running through December 2026, supports global pharmaceutical supply to military healthcare programs, covering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across...
- The Defense Logistics Agency's Medical Supply Chain issued a $4,028.55 delivery order to AmerisourceBergen Drug Corp on April 6, 2026, under its parent IDC with the Defense Logistics Agency Troop Support Medical. The parent IDC, valued at $999,999,999.00 and running through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a $36,529.98 delivery order to AmerisourceBergen Drug Corp on April 6, 2026, for pharmaceutical products under its parent Indefinite Delivery Contract with the DLA Troop Support Medical. The parent IDC, valued at $999,999,999.00 and running through December 2026, is a global pharmaceutical support vehicle enabling supply of brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to military healthcare programs...
- The Defense Logistics Agency Medical Supply Chain issued a $13,810.56 delivery order to AmerisourceBergen Drug Corp on March 16, 2026, for pharmaceutical distribution under a parent indefinite delivery contract with the DLA Troop Support Medical. The parent IDC, valued at $999,999,999.00 and running through December 2026, supports global pharmaceutical supply to military healthcare programs and covers brand-name and generic medications, vaccines, syringes, vials, and test kits across multiple...
- The Defense Logistics Agency Medical Supply Chain issued a $52,264.44 delivery order to AmerisourceBergen Drug Corp on March 10, 2026, for pharmaceutical supply under its parent Indefinite Delivery Contract with the DLA Troop Support Medical. The parent IDC, valued at $999,999,999.00 through December 2026, is a global pharmaceutical support vehicle enabling AmerisourceBergen to supply brand-name and generic medications, vaccines, and medical supplies to military healthcare programs worldwide....
- The Defense Logistics Agency's Medical Supply Chain issued an $11,731.48 delivery order to AmerisourceBergen Drug Corp on March 16, 2026, for pharmaceutical supply under the company's parent indefinite delivery contract with DLA Troop Support Medical. The parent IDC, valued at up to $999,999,999.00 and running through December 2026, is a single-award vehicle covering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally,...
- The Defense Logistics Agency Medical Supply Chain issued a $52,173 delivery order to AmerisourceBergen Drug Corp on March 26, 2026, for pharmaceutical products under the company's parent indefinite delivery contract with DLA Troop Support Medical. The parent IDC is valued at up to $999,999,999 and runs through December 2026, supporting global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order carries a firm fixed price structure and is...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA6HSDelivery Order
The Defense Logistics Agency Medical Supply Chain issued a $43,434.03 delivery order to AmerisourceBergen Drug Corp on April 6, 2026, for pharmaceutical supply under its parent indefinite delivery contract with the DLA Troop Support Medical. The parent IDC, valued at $999,999,999.00 and running through December 2026, supports global pharmaceutical distribution to military healthcare programs, covering brand-name and generic drugs, vaccines, specialty medications, and medical supplies across multiple therapeutic domains. Place of performance is Conshohocken, Pennsylvania. The order carries firm fixed pricing and was issued without a set-aside, with ultimate completion targeted for April 7, 2026.
Generated 7/5/26, 12:42 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.4k | 4/5/26 |